Videos

Sabroxy® is a clinically studied nootropic supporting brain health

Company Logo

Released By Sabinsa Corporation

In a 12-week randomized, double-blind, placebo-controlled trial, supplementation with 500 mg of Sabroxy® twice daily in older adults with self-reported memory complaints was associated with greater improvements in episodic memory and several computer-based cognitive tasks compared to the placebo.

LEARN MORE >> 

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters

Request more information from Sabinsa Corporation